Fulco, Charles P. http://orcid.org/0000-0002-6592-1279
Nasser, Joseph
Jones, Thouis R.
Munson, Glen
Bergman, Drew T. http://orcid.org/0000-0002-8314-7088
Subramanian, Vidya
Grossman, Sharon R.
Anyoha, Rockwell
Doughty, Benjamin R. http://orcid.org/0000-0003-0447-4468
Patwardhan, Tejal A.
Nguyen, Tung H.
Kane, Michael
Perez, Elizabeth M.
Durand, Neva C.
Lareau, Caleb A.
Stamenova, Elena K.
Aiden, Erez Lieberman
Lander, Eric S. http://orcid.org/0000-0003-2662-4631
Engreitz, Jesse M. http://orcid.org/0000-0002-5754-1719
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (1K99HG009917-01)
Article History
Received: 23 January 2019
Accepted: 25 October 2019
First Online: 29 November 2019
Competing interests
: E.S.L. serves on the Board of Directors for Codiak BioSciences and Neon Therapeutics, and serves on the Scientific Advisory Board of F-Prime Capital Partners and Third Rock Ventures; he is also affiliated with several nonprofit organizations including serving on the Board of Directors of the Innocence Project, Count Me In and Biden Cancer Initiative, and the Board of Trustees for the Parker Institute for Cancer Immunotherapy. He has served, and continues to serve, on various federal advisory committees. C.P.F., E.S.L. and J.M.E. are inventors on a patent application (no. WO2018064208A1) filed by the Broad Institute related to this work.